Your browser doesn't support javascript.
loading
Impact of racial disparities in follow-up and quality of colonoscopy on colorectal cancer outcomes.
Alagoz, Oguzhan; May, Folasade P; Doubeni, Chyke A; Fendrick, A Mark; Vahdat, Vahab; Estes, Chris; Ellis, Travelle; Limburg, Paul J; Brooks, Durado.
Afiliação
  • Alagoz O; Department of Industrial & Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA.
  • May FP; Department of Medicine, University of California Los Angeles (UCLA) Health and UCLA Kaiser Permanente Center for Health Equity, Los Angeles, CA, USA.
  • Doubeni CA; Department of Family and Community Medicine, College of Medicine, Comprehensive Cancer Center, Wexner Medical Center, The Ohio State University, Columbus, OH, USA.
  • Fendrick AM; Department of Internal Medicine and Department of Health Management and Policy, Division of General Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Vahdat V; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA.
  • Estes C; Exact Sciences Corporation, Madison, WI, USA.
  • Ellis T; Exact Sciences Corporation, Madison, WI, USA.
  • Limburg PJ; Exact Sciences Corporation, Madison, WI, USA.
  • Brooks D; Exact Sciences Corporation, Madison, WI, USA.
J Natl Cancer Inst ; 2024 Jul 24.
Article em En | MEDLINE | ID: mdl-39044335
ABSTRACT

BACKGROUND:

The benefits of colorectal cancer (CRC) screening programs rely on completing follow-up colonoscopy when a noncolonoscopy test is abnormal and on quality of colonoscopy screening as measured by the endoscopists' adenoma detection rate. Existing data demonstrate substantially lower follow-up colonoscopy rates and adenoma detection rate for Black Americans than White Americans. However, the contributions of racial differences in follow-up colonoscopy and adenoma detection rate on CRC outcomes have not been rigorously evaluated.

METHODS:

We used established and validated CRC-Adenoma Incidence and Mortality (CRC-AIM) model as our analysis platform, with inputs from published literature that report lower follow-up colonoscopy rates and adenoma detection rate in Black adults compared with White adults (15% and 10% lower, respectively). We simulated screening with annual fecal immunochemical test, triennial multitarget stool DNA, and colonoscopy every 10 years between ages 45 and 75 years using real-world utilization of the screening modalities vs no screening. We reported lifetime outcomes per 1000 Black adults.

RESULTS:

Elimination of Black-White disparities in follow-up colonoscopy rates would reduce CRC incidence and mortality by 5.2% and 9.3%, respectively, and improve life-years gained with screening by 3.4%. Elimination of Black-White disparities in endoscopists' adenoma detection rate would reduce CRC incidence and mortality by 9.4% and improve life-years gained by 3.7%. Elimination of both disparities would reduce CRC incidence and mortality by 14.6% and 18.7%, respectively, and improve life-years gained by 7.1%.

CONCLUSIONS:

This modeling study predicts eliminating racial differences in follow-up colonoscopy rates, and quality of screening colonoscopy would substantially reduce Black-White disparities in CRC incidence and mortality.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article